University of Istanbul
University of Istanbul researchers publish most recent findings
Published in Managed Care Business Week, June 20th, 2006
This trend article about University of Istanbul is an immediate alert from IncRx to identify developing directions of research.
Study 1: The Val34Leu polymorphism in te FXIII gene has a protective effect against myocardial infarction.
According to recent research from Turkey, "Activated factor XIII (FXIII) cross-links between fibrin monomers, thus increasing the clot stability and resistance to fibrinolysis. Congenital FXIII deficiency causes severe bleeding diathesis. Recently, a common polymorphism of the FXIII A subunit (FXIII Val34Leu) has been identified as a...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Managed Care Business Week
More Articles from Managed Care Business Week
- Collaborations
BenefitPoint and Symetra team up to enhance employee benefit choices - Medicare
America's Health Insurance Plans applauds CMS leadership in transparency of health care information - Aachen University
Platelet-monocyte aggregate formation is affected by phosphodiesterase III inhibition - Aarhus University Hospital
Hypocaloric diet and physical activity improved insulin sensitivity and inflammation obese - Addenbrookes Hospital, Cambridge
Studies from Addenbrookes Hospital, Cambridge highlight latest findings - All India Institute of Medical Sciences, New Delhi
Heterogeneous phenotypes of insulin resistance can identify metabolic syndrome in youth - More from this issue of Managed Care Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
